Locus Cell Co., Ltd. (TPEX:6891)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.00
-0.10 (-0.37%)
Mar 2, 2026, 1:23 PM CST
35.34%
Market Cap 5.42B
Revenue (ttm) 5.18M
Net Income (ttm) -164.24M
Shares Out 200.05M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 156,070
Average Volume 103,206
Open 27.10
Previous Close 27.10
Day's Range 26.55 - 27.10
52-Week Range 19.60 - 36.60
Beta 0.56
RSI 42.11
Earnings Date Apr 16, 2026

About Locus Cell

Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell therapy related products in Taiwan and the United States. The company is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Yu-Hsiang Chang
Employees 53
Stock Exchange Taipei Exchange
Ticker Symbol 6891
Full Company Profile

Financial Performance

In 2024, Locus Cell's revenue was 2.36 million, an increase of 480.30% compared to the previous year's 406,000. Losses were -113.02 million, 16.6% more than in 2023.

Financial Statements

News

There is no news available yet.